COMP <GO>
DVA vs JNJ // 10Y YIELD & FRED MACRO BETA
DaVita Inc. (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: DVA 6
— JNJ 7
▲ 10Y YIELD & FRED MACRO BETA LEADER: JNJ
LAST: $187.50 (-3.01%) • MKT CAP: $12.33B
macro-sensitivity
0.95
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
macro-sensitivity
1.08
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DVA VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DVA | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 67.90% | -26.90 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 29.20% | 25.50% | +3.70 | DVA | /roic <GO> |
| EV/EBITDA & P/E Valuation | 7.3x | 18.5x | -11.20 | DVA | /valuation <GO> |
| Free Cash Flow Yield | 10.63% | 2.97% | +7.66 | DVA | /fcf-yield <GO> |
| Operating Margin | 15.00% | 34.70% | -19.70 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 7.90% | 28.50% | -20.60 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 6.50% | 6.00% | +0.50 | DVA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.66 | 5.59 | -3.93 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 7.20% | -0.50 | DVA | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.3 | 60.4 | -6.02 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 0.95 | 1.08 | -0.13 | JNJ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 10.6x | 23.0x | -12.40 | DVA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $12.33B | $662.49B | -$650.16B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DVA REV | JNJ REV | DVA GROSS % | JNJ GROSS % | DVA FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $13.64B | $94.19B | 44.0% | 67.9% | $1.31B | $19.70B |
| FY 2024 | $12.82B | $88.82B | 44.0% | 69.1% | $1.47B | $19.84B |
| FY 2023 | $12.14B | $85.16B | 44.0% | 44.0% | $1.51B | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DVA // BETA 0.95
JNJ // BETA 1.08